Skip to content

Investigations Regarding B-cell Subsets in Humans

Investigations Regarding B-cell Subsets in Humans

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00926692
Enrollment
249
Registered
2009-06-23
Start date
2009-04-30
Completion date
2014-07-31
Last updated
2015-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

B-cells, CD5+, B1 Cells, Healthy Controls

Brief summary

The aim of this research is to define the human equivalent of mouse B1 cells.

Detailed description

The specific aim of this research project is to define the human equivalent of mouse B1 cells. This will be done by evaluating IgM secretion, surface markers, functional characteristics, V gene usage, N-region addition, and phosphorylation status of intracellular proteins, gene expression, sequencing of immunoglobulin genes, determination of antigenic specificity, replication history, and response to different stimuli. The goal of this project is to begin to the translation of decades of basic science research and research in the mouse model into the human system. It is believed that properly defining this B cell subset in humans will lead to better therapeutics, prognostics and prevention for a number of disease including infections, autoimmune disease, and cancer.

Interventions

OTHERBlood draw

Subject will have blood draw.

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject is considered by the physician to be a healthy adult.

Exclusion criteria

* Subject is under the age of 18 * Subject has an infection or is currently ill

Design outcomes

Primary

MeasureTime frameDescription
Presence of B-1 cells in humansdetermined over the years study in effectan equivalent cell type was isolated in humans

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026